ASH 2013: Dr. Adrian Wiestner Discusses Prognostic and Predictive Factors, the Nuances of 17p deletion and Residual Disease


In my blog I have posted the second part of Dr. Wiestner's interview that addresses some of the subtleties of CLL that we are gradually beginning to understand from the research begin done by his team at the NIH and others around the world.

We are moving the needle, but it is still not pointing at cure.

Stay strong. Merry Christmas.


Last edited by

1 Reply

  • Hi I think a lot of important issues are raised in this interview.One about long term. But no one has a crystal ball. Best wishes

You may also like...